Aquestive Therapeutics News - November 2, 2026

🔴 Aquestive Therapeutics is trading 5% down with no confirmed catalyst

Aquestive Therapeutics is trading 5.01% lower at $3.69, with no confirmed cause identified for the November 2 decline. - Q3 results are scheduled for November...

Aquestive Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 03, 2026

Aquestive Therapeutics is expected to report Q3 2026 revenue of $15.42 million and a consensus EPS loss of $0.10, with the stock trading at $5.24 against a...